Notified Bodies, Authorized Reps And The CE Mark: Post-Brexit Uncertainty Clouds Future Regulations
This article was originally published in The Gray Sheet
Executive Summary
The soon-to-be-adopted Medical Device and In Vitro Diagnostic Regulations in the European Union are expected to take effect in the next three to five years, when the UK could be separate from the EU. What are the potential regulatory implications of the "Brexit" for device firms in the UK and throughout Europe?
You may also be interested in...
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.
First Danish Notified Body Named Under EU's Medical Device Regulation
The EU now has a total of 45 notified bodies under the MDR.